Karl Kramer

The target landscape of clinical kinase drugs

Susan Klaeger, Stephanie Heinzlmeir, Mathias Wilhelm et al. · Science · 2017 · 845 citations · Full text

Tumor Biology, Proteomicsdb Database, Drug Target +14

C‐terminal domains of <i>Listeria monocytogenes</i> bacteriophage murein hydrolases determine specific recognition and high‐affinity binding to bacterial cell wall carbohydrates

Martin J. Loessner, Karl Kramer, Frank Ebel et al. · Molecular Microbiology · 2002 · 367 citations · Full text

Building ProteomeTools based on a complete synthetic human proteome

Daniel P. Zolg, Mathias Wilhelm, Karsten Schnatbaum et al. · Nature Methods · 2017 · 269 citations · Full text

Engineering, Biochemistry, Natural Sciences +6

Optimized Chemical Proteomics Assay for Kinase Inhibitor Profiling

Guillaume Médard, Fiona Pachl, Benjamin Ruprecht et al. · Journal of Proteome Research · 2015 · 134 citations

Target deconvolution of HDAC pharmacopoeia reveals MBLAC2 as common off-target

Severin Lechner, Martin Ian P. Malgapo, Christian Grätz et al. · Nature Chemical Biology · 2022 · 104 citations · Full text

Drug Target, Biochemistry, Medicine +5